REQUIREMENTS FOR ABSTRACT SUBMISSION
1. Title of the Abstract
placed at the top of the page
uppercase letters, bold type
length — no more than 12 words
2. Authors
Surname and initials — bold type
the presenting author’s surname must be underlined
maximum number of authors — no more than 3
3. Affiliation
if authors are affiliated with different institutions, a superscript index (¹,², etc.) is placed after the initials
the names of institutions are listed below, corresponding to the same indices
if there is one author or all authors are from the same institution, no indices are used
4. Scientific Supervisor
indicated on a separate line
5. Institution
provided on a new line after the information about authors and the scientific supervisor
Abstract Structure
The abstract must be structured and include the following sections:
Background — up to 100 words
Objective — up to 30 words
Materials and Methods — up to 150 words
Results — up to 300 words
Conclusions — up to 100 words
Ethical Considerations
Mandatory statement on approval by an Ethics Committee (Bioethics)
References
the reference list is provided at the end of the abstract
3–5 references are recommended
in-text citations should be indicated in square brackets, e.g. [1,3–5]
references must be formatted according to the Vancouver style
Example of Abstract Formatting
ON BREAST CANCER INCIDENCE IN AKMOLA REGION
Baurzhankyzy N.1, Telmanova Zh.B.2, Zhigitay D.R.3, Igisin N.S.4,1,2,5
1. Higher School of Medicine, Sh. Ualikhanov Kokshetau University, Kokshetau, Kazakhstan
2. Central Asian Institute for Medical Research, Astana, Kazakhstan
3. Kokshetau Higher Medical College, Kokshetau, Kazakhstan
4. Research Institute of Life and Health Sciences, Sh. Ualikhanov Kokshetau University, Kokshetau, Kazakhstan
5. Asian Pacific Organization for Cancer Prevention, Bishkek, Kyrgyzstan
Relevance. Breast cancer (BC) ranks first in the global cancer incidence structure, with over 2.3 million new cases registered annually [1]. It has been established that more than 81.5% of BC cases occur in countries with high or very high human development indices [2]. This study aims to assess the incidence of BC in the Akmola region of Kazakhstan.
Objective. To analyze the dynamics of breast cancer incidence in the Akmola region to assess trends and develop preventive measures.
Materials and Methods. This retrospective study was based on reporting data from the Ministry of Health of the Republic of Kazakhstan (Form 7, Form 35) for the period from 2009 to 2018 regarding new BC cases in the region. Descriptive and analytical methods of medical statistics were used [3], and calculations included average annual values (M), standard error (m), 95% confidence interval (95% CI), and annual growth/decline rates (%).
Results. During the study period, 1,977 new cases of BC were registered, accounting for 4.9% of all cases registered nationwide (40,199). The highest proportion of cases was observed in the 50-59 age group—665 cases, comprising 33.6% of the total. The average age of BC patients in the region was 58.5±0.4 years (95% CI=57.7–59.2). The study period showed an increase in the average age of patients from 57.3±0.9 years in 2009 to 60.3±0.7 years in 2018, with an average annual growth rate of +0.4%. The crude incidence rate also demonstrated an increase from 44.4±3.40/0000 in 2009 to 60.2±4.00/0000 in 2018, with an annual growth rate of +4.0%. The average crude incidence rate for BC among women in the Akmola region was 51.9±2.600/0000 (95% CI=46.8–57.1), reflecting the overall incidence level in the region. Age-specific incidence rates showed a unimodal increase with a peak in the 60–69 age group at 149.4±10.20/0000 (95% CI=129.5–169.4). Trends in age-specific BC incidence rates tended to increase in nearly all age groups except those under 30 years old (growth rate −12.6%).
Conclusions and Recommendations. Analysis of BC data among residents of the Akmola region revealed that overall incidence trends and age-specific trends showed an upward trajectory. The results of this study are recommended for use in monitoring and evaluating cancer control measures, particularly in assessing preventive actions and risk factors.
References
- Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available at: https://gco.iarc.who.int/today.
- Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). The Lancet Oncology. 2008;9(8):730-756. DOI: 10.1016/S1470-2045(08)70179-7.
- Petri A., Sabin K. Illustrative Medical Statistics. Educational manual. Translated into Russian, edited by V.P. Leonov. GEOTAR-Media, 2021. 232 p.